Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2007

01-10-2007 | Original Article

A Cost Analysis of Colonoscopy using Microcosting and Time-and-motion Techniques

Authors: Stephen G. Henry, MD, Reid M. Ness, MD, MPH, Renée A. Stiles, PhD, Ayumi K. Shintani, PhD, MPH, Robert S. Dittus, MD, MPH

Published in: Journal of General Internal Medicine | Issue 10/2007

Login to get access

Abstract

Background

The cost of an individual colonoscopy is an important determinant of the overall cost and cost-effectiveness of colorectal cancer screening. Published cost estimates vary widely and typically report institutional costs derived from gross-costing methods.

Objective

Perform a cost analysis of colonoscopy using micro-costing and time-and-motion techniques to determine the total societal cost of colonoscopy, which includes direct health care costs as well as direct non-health care costs and costs related to patients’ time. The design is prospective cohort. The participants were 276 contacted, eligible patients who underwent colonoscopy between July 2001 and June 2002, at either a Veterans’ Affairs Medical Center or a University Hospital in the Southeastern United States.

Major results

The median direct health care cost for colonoscopy was $379 (25%, 75%; $343, $433). The median direct non-health care and patient time costs were $226 (25%, 75%; $187, $323) and $274 (25%, 75%; $186, $368), respectively. The median total societal cost of colonoscopy was $923 (25%, 75%; $805, $1047). The median direct health care, direct non-health care, patient time costs, and total costs at the VA were $391, $288, $274, and $958, respectively; analogous costs at the University Hospital were $376, $189, $368, and $905, respectively.

Conclusion

Microcosting techniques and time-and-motion studies can produce accurate, detailed cost estimates for complex medical interventions. Cost estimates that inform health policy decisions or cost-effectiveness analyses should use total costs from the societal perspective. Societal cost estimates, which include patient and caregiver time costs, may affect colonoscopy screening rates.
Appendix
Available only for authorised users
Literature
1.
go back to reference Winawer S, Fletcher RH, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterol. 2003;124:544–60.CrossRef Winawer S, Fletcher RH, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterol. 2003;124:544–60.CrossRef
2.
go back to reference Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2006. Ca Cancer J Clin. 2006;56:11–25.PubMedCrossRef Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2006. Ca Cancer J Clin. 2006;56:11–25.PubMedCrossRef
3.
go back to reference Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterol. 2005;129:1151–62.CrossRef Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterol. 2005;129:1151–62.CrossRef
4.
go back to reference Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Fecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ. 1998;7:21–9.PubMedCrossRef Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Fecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ. 1998;7:21–9.PubMedCrossRef
5.
go back to reference Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol. 2000;95:1800–11.PubMedCrossRef Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol. 2000;95:1800–11.PubMedCrossRef
6.
go back to reference Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–61.PubMedCrossRef Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–61.PubMedCrossRef
7.
go back to reference Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst. 2000;92:557–63.PubMedCrossRef Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst. 2000;92:557–63.PubMedCrossRef
8.
go back to reference Ladabaum U, Phillips KA. Colorectal Cancer Screening: differential costs for younger versus older Americans. Am J Prev Med. 2006;30:378–84.PubMedCrossRef Ladabaum U, Phillips KA. Colorectal Cancer Screening: differential costs for younger versus older Americans. Am J Prev Med. 2006;30:378–84.PubMedCrossRef
9.
go back to reference Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterol. 1995;109:1781–90.CrossRef Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterol. 1995;109:1781–90.CrossRef
10.
go back to reference Bhattacharya I, Sack EM. Screening colonoscopy: the cost of common sense. Lancet. 1996;347:1744–5.PubMedCrossRef Bhattacharya I, Sack EM. Screening colonoscopy: the cost of common sense. Lancet. 1996;347:1744–5.PubMedCrossRef
11.
go back to reference Wagner JL, Herdman RC, Wadhwa S. Cost-effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807–17.PubMed Wagner JL, Herdman RC, Wadhwa S. Cost-effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807–17.PubMed
12.
go back to reference Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573–84.PubMed Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573–84.PubMed
13.
go back to reference Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002;162:163–8.PubMedCrossRef Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002;162:163–8.PubMedCrossRef
14.
go back to reference Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:176–213. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:176–213.
15.
go back to reference Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care. 2003;19:384–95.PubMedCrossRef Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care. 2003;19:384–95.PubMedCrossRef
16.
go back to reference Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs. Ann Intern Med. 1999;130:525–30.PubMed Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs. Ann Intern Med. 1999;130:525–30.PubMed
17.
go back to reference Stiles RA, Mick SS. Components of the costs of controlling quality: a transaction cost economics approach. Hosp Health Serv Adm. 1997;42:205–12.PubMed Stiles RA, Mick SS. Components of the costs of controlling quality: a transaction cost economics approach. Hosp Health Serv Adm. 1997;42:205–12.PubMed
21.
go back to reference Levin B, Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action. Cancer. 2002;95:1618–28.PubMedCrossRef Levin B, Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action. Cancer. 2002;95:1618–28.PubMedCrossRef
22.
go back to reference Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Colorectal cancer screening: health impact and cost-effectiveness. Am J Prev Med. 2006;31:80–9.PubMedCrossRef Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Colorectal cancer screening: health impact and cost-effectiveness. Am J Prev Med. 2006;31:80–9.PubMedCrossRef
23.
go back to reference O’Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community based-flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol. 2004;19:38–47.PubMedCrossRef O’Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community based-flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol. 2004;19:38–47.PubMedCrossRef
24.
go back to reference Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137:96–104.PubMed Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137:96–104.PubMed
Metadata
Title
A Cost Analysis of Colonoscopy using Microcosting and Time-and-motion Techniques
Authors
Stephen G. Henry, MD
Reid M. Ness, MD, MPH
Renée A. Stiles, PhD
Ayumi K. Shintani, PhD, MPH
Robert S. Dittus, MD, MPH
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 10/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0281-6

Other articles of this Issue 10/2007

Journal of General Internal Medicine 10/2007 Go to the issue

Reflections

One-on-One

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.